Deposition of inhaled particles in the lungs

AF Tena, PC Clarà - Archivos de Bronconeumología (English Edition), 2012 - Elsevier
Inhaled medication is the first-line treatment of diseases such as asthma or chronic
obstructive pulmonary disease. Its effectiveness is related to the amount of drug deposited …

In silico models of aerosol delivery to the respiratory tract—development and applications

PW Longest, LT Holbrook - Advanced drug delivery reviews, 2012 - Elsevier
This review discusses the application of computational models to simulate the transport and
deposition of inhaled pharmaceutical aerosols from the site of particle or droplet formation to …

In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals

K Nahar, N Gupta, R Gauvin, S Absar, B Patel… - European journal of …, 2013 - Elsevier
Delivery of therapeutic agents via the pulmonary route has gained significant attention over
the past few decades because this route of administration offers multiple advantages over …

Numerical investigation of the interaction, transport and deposition of multicomponent droplets in a simple mouth-throat model

X Chen, Y Feng, W Zhong, C Kleinstreuer - Journal of aerosol science, 2017 - Elsevier
A basic analysis of inhaled multicomponent droplet-vapor interaction and subsequent
aerosol deposition is very important for the understanding of natural phenomena as well as …

Delivery technologies for orally inhaled products: an update

C Moon, HDC Smyth, AB Watts, RO Williams III - AAPS PharmSciTech, 2019 - Springer
Orally inhaled products have well-known benefits. They allow for effective local
administration of many drugs for the treatment of pulmonary disease, and they allow for …

Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols

P Worth Longest, M Hindle - Aerosol Science and Technology, 2011 - Taylor & Francis
Enhanced excipient growth (EEG) is a newly proposed respiratory delivery strategy in which
submicrometer or nanometer particles composed of a drug and hygroscopic excipient are …

Nanoparticle delivery platforms for RNAi therapeutics targeting COVID-19 disease in the respiratory tract

Y Zhang, JG Almazi, HX Ong, MD Johansen… - International journal of …, 2022 - mdpi.com
Since December 2019, a pandemic of COVID-19 disease, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread across the globe. At …

Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways

G Tian, PW Longest, G Su, M Hindle - Annals of biomedical engineering, 2011 - Springer
The objective of this study was to evaluate the delivery of inhaled pharmaceutical aerosols
using an enhanced condensational growth (ECG) approach in an airway model extending …

Targeting aerosol deposition to and within the lung airways using excipient enhanced growth

G Tian, PW Longest, X Li, M Hindle - Journal of aerosol medicine …, 2013 - liebertpub.com
Background: Previous studies have characterized the size increase of combination
submicrometer particles composed of a drug and hygroscopic excipient when exposed to …

Influence of weather and seasonal variations in temperature and humidity on supersaturation and enhanced deposition of submicron aerosols in the human …

A Ishmatov - Atmospheric Environment, 2020 - Elsevier
In this review, all available data on the effects of supersaturation in human airways were
summarized and analysed, and the most critical parameters identified. The analysis shows …